Evidence map›Paper›PMID 38893309›Full record

ArticleMolecules (Basel, Switzerland)2024

Cyanoacetohydrazide as a Novel Derivatization Agent for the Determination of UHPLC-HRMS Steroids in Urine.

Azamat Temerdashev, Maria Zorina, Yu-Qi Feng, Elina Gashimova, Victor V Dotsenko, Vitalij Ioutsi, Sanka N Atapattu

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Azamat TemerdashevAnalytical Chemistry Department, Kuban State University, Krasnodar 350040, Russia.
Maria ZorinaAnalytical Chemistry Department, Kuban State University, Krasnodar 350040, Russia.ORCID 0000-0003-2882-7600
Yu-Qi FengSchool of Bioengineering and Health, Wuhan Textile University, Wuhan 430415, China.ORCID 0000-0003-1107-5385
Elina GashimovaAnalytical Chemistry Department, Kuban State University, Krasnodar 350040, Russia.ORCID 0000-0002-9618-7580
Victor V DotsenkoAnalytical Chemistry Department, Kuban State University, Krasnodar 350040, Russia.ORCID 0000-0001-7163-0497
Vitalij IoutsiEndocrinology Research Centre, Moscow 117292, Russia.
Sanka N AtapattuCanAm Bioresearch Inc., Winnipeg, MB R3T 6C6, Canada.ORCID 0000-0003-2647-2228

Funding

National Natural Science Foundation of China 22361132526Russian Science Foundation 24-43-00003
6 · The paper itself

Abstract

The possibility of cyanoacetohydrazide usage as a novel derivatizing agent is demonstrated in the presented article, and a comparison with hydroxylamine as the most commonly used reagent is provided. Optimal conditions for steroid derivatization with cyanoacetohydrazide are provided. According to the collected data, the maximum yield of derivatives was observed at pH 2.8 within 70 min at 40 °C with 5 ng/mL limit of detection for all investigated analytes. It was shown that cyanoacetohydrazide derivatives produces both syn- and anti-forms as well as hydroxylamine, and their ratios were evaluated and shown in presented work. An efficiency enchantment from two to up to five times was achieved with a novel derivatization reagent. Its applicability for qualitative analysis of steroids in urine was presented at real samples. Additionally, the reproducible fragmentation of the derivatizing agent in collision-induced dissociation offers opportunities for simplified non-targeted steroidomic screening. Furthermore, cyanoacetohydrazide increases ionization efficiency in positive mode, which can eliminate the need for redundant high-resolution instrument runs required for both positive and negative mode analyses.

Indexed as

SteroidsChromatography, High Pressure LiquidHumansHydrazinesLimit of DetectionTandem Mass SpectrometryHydrazinesSteroidscyanoacetohydrazidederivatizationLC-HRMSnon-targeted screeningsteroidomicssteroidstestosterone

Identifiers

PMID38893309
PMCPMC11173670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.